{"name":"Tanvex BioPharma USA, Inc.","slug":"tanvex-biopharma-usa-inc","ticker":"","exchange":"","domain":"tanvexusa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NYPOZI","genericName":"FILGRASTIM-TXID","slug":"filgrastim-txid","indication":"Febrile Neutropenia in Nonmyeloid Malignancies","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TX05 (trastuzumab)","genericName":"TX05 (trastuzumab)","slug":"tx05-trastuzumab","indication":"HER2-positive metastatic breast cancer","status":"phase_3"}]}],"pipeline":[{"name":"NYPOZI","genericName":"FILGRASTIM-TXID","slug":"filgrastim-txid","phase":"marketed","mechanism":"G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function.","indications":["Febrile Neutropenia in Nonmyeloid Malignancies","Neutrophil Recovery in AML","Neutropenia in BMT","Progenitor Cell Mobilization","Severe Chronic Neutropenia"],"catalyst":""},{"name":"TX05 (trastuzumab)","genericName":"TX05 (trastuzumab)","slug":"tx05-trastuzumab","phase":"phase_3","mechanism":"Trastuzumab is a monoclonal antibody that binds to HER2 receptors on cancer cells, blocking growth signals and triggering immune-mediated cell death.","indications":["HER2-positive metastatic breast cancer","HER2-positive early-stage breast cancer (adjuvant/neoadjuvant)","HER2-positive metastatic gastric cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQVzZtT2w1UFEyQ3VqOWhXQVVOOHZJc0NyR2txZEhGMEM2d3hUZXZhRng5V1hjOVlISWNscGl1MzJSVC1KS1VmRnl2Nm56OWx0MlczeFZCTHRNNjNobFFmT2tZSGFsUEQ4bElSdGxNLUNlS214bExia2FLXzNMRXFnTFZoWXI2M0NlOWtZWmtHY2JPVmlxQ1hGbDIxdlhQbTRodGFXRjdMeHFaQ1NjdGxN?oc=5","date":"2025-05-22","type":"pipeline","source":"Fierce Pharma","summary":"CDMO Bora Biologics expands operations in San Diego in wake of acquisition by Tanvex - Fierce Pharma","headline":"CDMO Bora Biologics expands operations in San Diego in wake of acquisition by Tanvex","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNcW9vc3NpTzdpeEtLLW9lU0pSdE1SSW94NEhpVW9OOFd5U2tGQ3QzdVU2UDZQUEs3djd4WVFLLVRlRUloZVJ3a1pQd1JsWWloM29YLTliVDdJLU1ndVh1Y3ZnUTIzcG1ZeTFqVHFWVFRrdjVHUHoxN2hpbDlFLUI1b1JzSWpDWFg0VXBpdWRoUmp6azFyMVJVT3paN2g1OTgzaUE?oc=5","date":"2025-01-07","type":"patent","source":"BioWorld News","summary":"Taiwan’s Tanvex receives second CRL for Herceptin biosimilar - BioWorld News","headline":"Taiwan’s Tanvex receives second CRL for Herceptin biosimilar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNQVd4TFBxcDVXT0hZNk1DbTJBa3JGRjBldHhZaXFyVDZRZmIwYXdVWE4tWFBGNHk1X1RtWWRrZmZZTi1EVjB3WFVlRzhwaEpoMHRBZEw3WTNRUUdlRjlzamxUNDc0blVnVkVxYjZnQk00R0hpSXFBVFRHRjBqaS1ZNGJmaWM4UElXdWZWSGZveGtYWWR4dHo1NHNB?oc=5","date":"2024-12-22","type":"pipeline","source":"Contract Pharma","summary":"Norwich Pharmaceuticals Is Now Norwich Pharma Services - Contract Pharma","headline":"Norwich Pharmaceuticals Is Now Norwich Pharma Services","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOd2JxZ0p3TUI3bzV6eVNiYkJnTXNBYURsR1BRNkl0dkZGYVlGbER5SVUzcGNHakRGNUMwSlh5c2xMZGpfRV9aNXFzV2RXSV9nMEd2N2E5OXYwRkJyLVhnXzBYczRsc3BpbDgtMHhFTGh4bmN2eHZrV2liLTRUX1VHaC1nM3VVNmNWSzBkV3dhaUVXNFZiUDBlQklHYURJcC00T0IwdHpfakQyWEdIVUU4QVJ3?oc=5","date":"2024-11-22","type":"pipeline","source":"Contract Pharma","summary":"Vetter Strengthens Senior Management Team for Further Sustainable Growth - Contract Pharma","headline":"Vetter Strengthens Senior Management Team for Further Sustainable Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQSVJ5UWpFcEJUMHdmb0JmaW13WjdPbnhYaEhGSTVUdXRSU2tfQ21OZmlETGU1T1YzRFBGR3o5WTRKSGl6Vk9abU01dl9vNWlUeGVlWTd2bnN3a3NKVGZDSWxkdTFvTEZTTXZUdWJBNnBFcXB1Ml9pX3Z6aGU4ZVhVbTFwTXFkRUY0ZHo1MGIyRW1qYldOVTVDeG05ZkhqdTlFb2VMcHZ5TTh1bF9O?oc=5","date":"2024-09-05","type":"pipeline","source":"newswire.com","summary":"Tanvex BioPharma Forging Strategic Alliance With Bora Pharmaceuticals - newswire.com","headline":"Tanvex BioPharma Forging Strategic Alliance With Bora Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNMlRmZndQM09qYXdkc3cwRWJGVkV6WWViM0l6ZHlpMG5NM1llY085enY0QjNLQlJVMzJfTVVpWS1YZy1lMVpQY3E0VzFuRElVNHVfLW9peVp2R3NTampUQmZ4eE1ubmdabW9mdW1BMXNfYXltNS1Rcnl3ZV82WTVXQzNqYUpJWWhCQ0ZMSEJfa3JlZUNCSVU5dFE5QlpkY29hMjhXU1Q5OVhaSFZKVHlYSGk4aw?oc=5","date":"2024-08-28","type":"pipeline","source":"Contract Pharma","summary":"Bora Pharmaceuticals Makes Strategic Investment in Tanvex Biopharma - Contract Pharma","headline":"Bora Pharmaceuticals Makes Strategic Investment in Tanvex Biopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQZGhSLWlZUDVWYXoyVTZqQzBtamVTc0J3dEd0b3hDRmFYLXZVWERKV3N6UmJRa3BYVnY5blBCV0FSN3QtdHpSVkFNbTdoV3hfTk5IalFqUEpHQ294TDZ1SVlfT1lKbnlCcmZBSHZfQUkyN28wa0d5d2FfYmJxMnNIVmtMNDAySmFtLVVPLWNqRFk5Y18zc1ZWeHo2MFYwUVhHNWNxUWdqWWFpYWxqVmNVMmtvaHljRUZKWTBSS2tQUXZkRnB6NVB4MklBRU8?oc=5","date":"2024-07-03","type":"regulatory","source":"geneonline.com","summary":"Tanvex BioPharma Secures Asia's First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market - geneonline.com","headline":"Tanvex BioPharma Secures Asia's First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOWk00NEtBWk53S3Q5Xzhla0ZPLWxtdXFrWmVUZ2ctc3o5bEx0dERBY3ZNUTZFSG1rZmZsT1huZnNCU3VDM05EbXFPMWx5b1ZsMkpkQlJoMjE2cHd2WUV5UGkxZkRUaW4xMi1VUVd2WURfUjZCMjB2TDc5TEFKZ084eDcyVnNBS21uWFVmVEhmUWtWU1pvd0J0MlVDMmp6YW4xNlJfczFR?oc=5","date":"2020-01-28","type":"pipeline","source":"Contract Pharma","summary":"New project to advance platelet-based therapeutics for patients - Contract Pharma","headline":"New project to advance platelet-based therapeutics for patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPUTZENlEtMW5pTExvSVMwSUR3TXNIR19DRG9BZXdiZ3lPMER2Z1ZzemtBUGphcG1ZX25OeElKdDg1UF9KOWV1c0RENEJQSEh0ejZMUTV2RHBvT29KV3ZhWi05bEp6WU91clhzRGpOSFVneEZycHJhcjBibVRUd1ZPMEVKUTJTaEZXeDY1cThsUEpoTDZ3NjZCa05R?oc=5","date":"2017-05-22","type":"pipeline","source":"Contract Pharma","summary":"Sharp Packaging US Surpasses 50 Quality Certifications - Contract Pharma","headline":"Sharp Packaging US Surpasses 50 Quality Certifications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNblpFSTByZ0x3THBwbGo5T0xET092T0x5ZjFsTlJXWU9zLXJRc2FvWDlsWkZfTS1tdlFrMWZudFpFbkFNSjJBdlp5Y1hPOXlrakpDR2dWNTVGb1REQWFpbVhaQ043NHItUWlLb1RJSXZiS2NaV2M4NW1sSGRXbUd2Z3VoenRRc2lYQVZGcWk0UndUcXRKMEY2bWpteE95a2RqdmJ1akVpMnJwMVM0ZXJ4OXo3Vmc2MjdyMHVhWDNwZmFaZw?oc=5","date":"2017-05-09","type":"deal","source":"Contract Pharma","summary":"Sharp Acquires Daiichi Sankyo Inc.’s Pharmaceutical Packaging Facility in Bethlehem, PA - Contract Pharma","headline":"Sharp Acquires Daiichi Sankyo Inc.’s Pharmaceutical Packaging Facility in Bethlehem, PA","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}